CHMP5 and COVID-19: As many PWHs are likely at high risk of becoming infected with SARS-CoV-2 and severe COVID-19 due to comorbid conditions (41, 42), the development of IgM and IgG Ab against the spike protein could likely indicate protection against reinfections and potential protection after vaccination against SARS-CoV-2.